TY - JOUR
T1 - UK research priority setting for childhood neurological conditions
AU - Cadwgan, Jill
AU - Goodwin, Jane
AU - Babcock, Barbara
AU - Brick, Molly
AU - Chin, Richard
AU - Easton, Ava
AU - Green, Ben
AU - Hannan, Siobhan
AU - Inward, Rhys P.D.
AU - Kinsella, Suzannah
AU - King, Callum
AU - Kurian, Manju A.
AU - Levine, Phillip
AU - Mallick, Andrew A.
AU - Parr, Jeremy
AU - Partridge, Carol Anne
AU - Amin, Sam
AU - Lumsden, Dan
AU - Cross, J. Helen
AU - Lim, Ming J.
AU - UK Childhood Neurological Disorders PSP Group
AU - Disorders PSP Group
AU - Childs, Anne Marie
AU - Ganesan, Vijeya
AU - Hart, Anthony
AU - Kneen, Rachel
AU - McFarland, Robert
AU - Wassmer, Evangeline
AU - Whitehouse, William P.
AU - Williams, Ruth
AU - Arichi, Tom
AU - Burford, Vicky
AU - Crombie, Sarah
AU - Damodaran, Laavanya
AU - Eunson, Paul
AU - Gringras, Paul
AU - Gordon, Anne
AU - Harrop, Emily
AU - Hart, Anthony
AU - Martin, Catherine
AU - Rush, Carla
AU - Tuffrey, Catherine
N1 - Publisher Copyright:
© 2024 The Author(s). Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
PY - 2024/7/16
Y1 - 2024/7/16
N2 - Aim: To identify research priorities regarding the effectiveness of interventions for children and young people (CYP) with childhood neurological conditions (CNCs). These include common conditions such as epilepsies and cerebral palsy, as well as many rare conditions. Method: The National Institute for Health and Care Research (NIHR) and the James Lind Alliance (JLA) champion and facilitate priority setting partnerships (PSPs) between patients, caregivers, and clinicians (stakeholders) to identify the most important unanswered questions for research (uncertainties). A NIHR–JLA and British Paediatric Neurology Association collaboration used the JLA PSP methodology. This consisted of two surveys to stakeholders: survey 1 (to identify uncertainties) and survey 2 (a prioritization survey). The final top 10 priorities were agreed by consensus in a stakeholder workshop. Results: One hundred and thirty-two charities and partner organizations were invited to participate. In survey 1, 701 participants (70% non-clinicians, including CYP and parent and caregivers) submitted 1800 uncertainties from which 44 uncertainties were identified for prioritization in survey 2; from these, 1451 participants (83% non-clinicians) selected their top 10 priorities. An unweighted amalgamated score across participant roles was used to select 26. In the final workshop, 14 health care professionals, 11 parent and caregivers, and two CYP ranked the 26 questions to finalize the top 10 priorities. Ten top priority questions were identified regarding interventions to treat CYP with CNCs and their associated comorbidities, for example, sleep, emotional well-being, and distressing symptoms. Interpretation: The results of this study will inform research into the effectiveness of interventions for children with neurological conditions.
AB - Aim: To identify research priorities regarding the effectiveness of interventions for children and young people (CYP) with childhood neurological conditions (CNCs). These include common conditions such as epilepsies and cerebral palsy, as well as many rare conditions. Method: The National Institute for Health and Care Research (NIHR) and the James Lind Alliance (JLA) champion and facilitate priority setting partnerships (PSPs) between patients, caregivers, and clinicians (stakeholders) to identify the most important unanswered questions for research (uncertainties). A NIHR–JLA and British Paediatric Neurology Association collaboration used the JLA PSP methodology. This consisted of two surveys to stakeholders: survey 1 (to identify uncertainties) and survey 2 (a prioritization survey). The final top 10 priorities were agreed by consensus in a stakeholder workshop. Results: One hundred and thirty-two charities and partner organizations were invited to participate. In survey 1, 701 participants (70% non-clinicians, including CYP and parent and caregivers) submitted 1800 uncertainties from which 44 uncertainties were identified for prioritization in survey 2; from these, 1451 participants (83% non-clinicians) selected their top 10 priorities. An unweighted amalgamated score across participant roles was used to select 26. In the final workshop, 14 health care professionals, 11 parent and caregivers, and two CYP ranked the 26 questions to finalize the top 10 priorities. Ten top priority questions were identified regarding interventions to treat CYP with CNCs and their associated comorbidities, for example, sleep, emotional well-being, and distressing symptoms. Interpretation: The results of this study will inform research into the effectiveness of interventions for children with neurological conditions.
UR - http://www.scopus.com/inward/record.url?scp=85198751445&partnerID=8YFLogxK
U2 - 10.1111/dmcn.16021
DO - 10.1111/dmcn.16021
M3 - Article
AN - SCOPUS:85198751445
SN - 0012-1622
JO - Developmental Medicine and Child Neurology
JF - Developmental Medicine and Child Neurology
ER -